‘The Venable team is extremely responsive and always willing to make time for their clients no matter the time or day an issue hits. Ability to help make sense of how regulators are thinking about emerging privacy and security issues.’ ‘The Venable team is always willing and able to engage on thorny privacy and security concerns, and excels at working through complex questions with their client’s stakeholders.
Jason Rose co-chairs the group alongside Hardway. During his career, Bruce Parker has been lead trial counsel in four mass torts and as well as his advocacy skills, he is also recognized for his ‘ fantastic expertise in epidemiology and science’. As part of his broad trial practice, Craig Thompson is regularly engaged in pharmaceutical product liability litigation, including his current role as co-national counsel to Takeda in litigation related to its proton-pump inhibitor medications. Kathleen Hardway regularly serves on nationwide trial teams in complex pharmaceutical disputes and is particularly adept at working with expert witnesses. The Baltimore-based team also has niche expertise defending vaccine manufacturers in litigation brought by plaintiffs following adverse reactions and side effects. The healthcare and life sciences sector is the centerpiece of Venable LLP‘s accomplished national product liability offering and sees the firm regularly engaged as national counsel overseeing the litigation strategy for many high-profile clients including Merck. Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
0 kommentar(er)
